Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-15T05:20:52.819Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (JUNE 2007)

Published online by Cambridge University Press:  01 July 2007

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 10 , Issue 7 , July 2007 , e14
Copyright
Copyright © Cambridge University Press 2007

References

1.Alarmo, EL, Kuukasjarvi, T, Karhu, R, Kallioniemi, A. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 2007; 103: 239–246.CrossRefGoogle ScholarPubMed
2.Boehm, JS, Zhao, JJ, Yao, J, Kim, SY, Firestein, R, Dunn, IF, Sjostrom, SK, Garraway, LA, Weremowicz, S, Richardson, AL, Greulich, H, Stewart, CJ, Mulvey, LA, Shen, RR, Ambrogio, L, Hirozane-Kishikawa, T, Hill, DE, Vidal, M, Meyerson, M, Grenier, JK, Hinkle, G, Root, DE, Roberts, TM, Lander, ES, Polyak, K, Hahn, WC. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007; 129: 1065–1079.CrossRefGoogle ScholarPubMed
3.Chang, Y, Zuka, M, Perez-Pinera, P, Astudillo, A, Mortimer, J, Berenson, JR, Deuel, TF. Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc Natl Acad Sci USA 2007; 104: 10888–10893.CrossRefGoogle ScholarPubMed
4.Desmedt, C, Piette, F, Loi, S, Wang, YX, d’assignies, MS, Bergh, J, Lidereau, R, Ellis, P, Harris, AL, Klijn, JGM, Foekens, JA, Cardoso, F, Piccart, MJ, Buyse, M, Sotiriou, C. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007; 13: 3207–3214.CrossRefGoogle ScholarPubMed
5.Easton, DF, Pooley, KA, Dunning, AM, Pharoah, PDP, Thompson, D, Ballinger, DG, Struewing, JP, Morrison, J, Field, H, Luben, R, Wareham, N, Ahmed, S, Healey, CS, Bowman, R, Luccarini, C, Conroy, D, Shah, M, Munday, H, Jordan, C, Perkins, B, West, J, Redman, K, Meyer, KB, Haiman, CA, Kolonel, LK, Henderson, BE, Le Marchand, L, Brennan, P, Sangrajrang, S, Gaborieau, V, Odefrey, F, Shen, CY, Wu, PE, Wang, HC, Eccles, D, Evans, DG, Peto, J, Fletcher, O, Johnson, N, Seal, S, Stratton, MR, Rahman, N, Chenevix-Trench, G, Bojesen, SE, Nordestgaard, BG, Axelsson, CK, Garcia-Closas, M, Brinton, L, Chanock, S, Lissowska, J, Peplonska, B, Nevanlinna, H, Fagerholm, R, Eerola, H, Kang, D, Yoo, KY, Noh, DY, Ahn, SH, Hunter, DJ, Hankinson, SE, Cox, DG, Hall, P, Wedren, S, Liu, J, Low, YL, Bogdanova, N, Schuermann, P, Doerk, T, Tollenaar, R, Jacobi, CE, Devilee, P, Klijn, JGM, Sigurdson, AJ, Doody, MM, Alexander, BH, Zhang, J, Cox, A, Brock, IW, MacPherson, G, Reed, MWR, Couch, FJ, Goode, EL, Olson, JE, Meijers-Heijboer, H, van den Ouweland, A, Uitterlinden, A, Rivadeneira, F, Milne, RL, Ribas, G, Gonzalez-Neira, A, Benitez, J, Hopper, JL, McCredie, M, Southey, M, Giles, GG, Schroen, C, Justenhoven, C, Brauch, H, Hamann, U, Ko, YD, et al. . Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 477: 1087–1093.CrossRefGoogle Scholar
6.Esseghir, S, Kennedy, A, Seedhar, P, Nerurkar, A, Poulsom, R, Reis, JS, Isacke, CM. Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin Cancer Res 2007; 13: 3164–3173.CrossRefGoogle Scholar
7.Gaedcke, J, Traub, F, Milde, S, Wilkens, L, Stan, A, Ostertag, H, Christgen, M, von Wasielewski, R, Kreipe, HH. Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol 2007; 20: 864–870. Epub 1 June 2007.CrossRefGoogle ScholarPubMed
8.Gudmundsdottir, K, Lord, CJ, Ashworth, A. The proteasome is involved in determining differential utilization of double-strand break repair pathways. Oncogene 2007, June 11; [Epub ahead of print], doi:10.1038/sj.onc.1210579.CrossRefGoogle ScholarPubMed
9.Herynk, MH, Parra, I, Cui, Y, Beyer, A, Wu, MF, Hilsenbeck, SG, Fuqua, SAW. Association between the estrogen receptor α A908G mutation and outcomes in invasive breast cancer. Clin Cancer Res 2007; 13: 3235–3243.CrossRefGoogle ScholarPubMed
10.Holmes, MD, Morin, S, Chen, WY, Kroenke, CH, Spiegelman, D, Colditz, GA. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007; 120: 2672–2677.CrossRefGoogle ScholarPubMed
11.Jonsson, G, Staaf, J, Olsson, E, Heidenblad, M, Vallon-Christersson, J, Osoegawa, K, de Jong, P, Oreclsson, S, Ringner, M, Hoglund, M, Borg, A. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007; 46: 543–558.CrossRefGoogle ScholarPubMed
12.Jung, EJ, Moon, HG, Cho, BI, Jeong, CY, Joo, YT, Lee, YJ, Hong, SC, Choi, SK, Ha, WS, Kim, JW, Lee, CW, Lee, JS, Park, ST. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 2007; 120: 2331–2338.CrossRefGoogle ScholarPubMed
13.Kariagina, A, Aupperlee, MD, Haslam, SZ. Progesterone receptor isoforms and proliferation in the rat mammary gland during development. Endocrinology 2007; 148: 2723–2736.CrossRefGoogle ScholarPubMed
14.Kim, CG, Choi, BH, Son, SW, Yi, SJ, Shin, SY, Lee, YH. Tamoxifen-induced activation of p21 (Waf1/Cip1) gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. Cell Signal 2007; 19: 1290–1300.CrossRefGoogle ScholarPubMed
15.Lissowska, J, Gaudet, MM, Brinton, LA, Chanock, SJ, Peplonska, B, Welch, R, Zatonski, W, Szeszenia-Dabrowska, N, Park, S, Sherman, M, Garcia-Closas, M. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population–based case-control study and meta-analyses. Int J Cancer 2007; 120: 2696–2703.CrossRefGoogle Scholar
16.Nair, SK, Verma, A, Thomas, TJ, Chou, TC, Gallo, MA, Shirahata, A, Thomas, T. Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Lett 2007; 250: 311–322.CrossRefGoogle ScholarPubMed
17.Olofsson, MH, Ueno, T, Pan, Y, Xu, R, Cai, F, van der Kuip, H, Muerdter, TE, Sonnenberg, M, Aulitzk, WE, Schwarz, S, Andersson, E, Shoshan, MC, Havelka, AM, Toi, M, Linder, S. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res 2007; 13: 3198–3206.CrossRefGoogle ScholarPubMed
18.Swanton, C, Marani, M, Pardo, O, Warne, PH, Kelly, G, Sahai, E, Elustondo, F, Chang, J, Temple, J, Ahmed, AA, Brenton, JD, Downward, J, Nicke, B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell 2007; 11: 498–512.CrossRefGoogle ScholarPubMed
19.Zheng, AP, Kallio, A, Harkonen, P. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. Endocrinology 2007; 148: 2764–2777.CrossRefGoogle ScholarPubMed